155 related articles for article (PubMed ID: 34602465)
1. Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
Fukuda H; Ono R; Maeda M; Murata F
J Alzheimers Dis; 2021; 84(2):807-817. PubMed ID: 34602465
[TBL] [Abstract][Full Text] [Related]
2. Household Income Relationship With Health Services Utilization and Healthcare Expenditures in People Aged 75 Years or Older in Japan: A Population-Based Study Using Medical and Long-term Care Insurance Claims Data.
Hamada S; Takahashi H; Sakata N; Jeon B; Mori T; Iijima K; Yoshie S; Ishizaki T; Tamiya N
J Epidemiol; 2019 Oct; 29(10):377-383. PubMed ID: 30249946
[TBL] [Abstract][Full Text] [Related]
3. Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims data.
Brüggenjürgen B; Andersohn F; Ezzat N; Lacey L; Willich S
J Med Econ; 2015 Jun; 18(6):466-73. PubMed ID: 25692902
[TBL] [Abstract][Full Text] [Related]
4. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
[TBL] [Abstract][Full Text] [Related]
5. The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan.
Mori T; Hamada S; Yoshie S; Jeon B; Jin X; Takahashi H; Iijima K; Ishizaki T; Tamiya N
BMC Geriatr; 2019 Mar; 19(1):69. PubMed ID: 30841859
[TBL] [Abstract][Full Text] [Related]
6. Disease Burden and Progression in Patients with New-Onset Mild Cognitive Impairment and Alzheimer's Disease Identified from Japanese Claims Data: Evidence from the LIFE Study.
Fukuda H; Kanzaki H; Murata F; Maeda M; Ikeda M
J Alzheimers Dis; 2023; 95(4):1559-1572. PubMed ID: 37718811
[TBL] [Abstract][Full Text] [Related]
7. The adoption of pharmaceutical innovation and its impact on the treatment costs for Alzheimer's disease in Taiwan.
Lo TF; Hsieh CR
J Ment Health Policy Econ; 2014 Sep; 17(3):107-17. PubMed ID: 25543114
[TBL] [Abstract][Full Text] [Related]
8. The effects of raising the long-term care insurance co-payment rate on the utilization of long-term care services.
Soga Y; Murata F; Maeda M; Fukuda H
Geriatr Gerontol Int; 2020 Jul; 20(7):685-690. PubMed ID: 32445437
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Alzheimer's Disease Dementia in Japan.
Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
[TBL] [Abstract][Full Text] [Related]
10. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
11. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
Fukuda H; Yano T; Shimono N
Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
[TBL] [Abstract][Full Text] [Related]
12. Micro data analysis of medical and long-term care utilization among the elderly in Japan.
Hashimoto H; Horiguchi H; Matsuda S
Int J Environ Res Public Health; 2010 Aug; 7(8):3022-37. PubMed ID: 20948944
[TBL] [Abstract][Full Text] [Related]
13. Effects of a financial incentive scheme for dementia care on medical and long-term care expenditures: A propensity score-matched analysis using LIFE study data.
Kawabata J; Fukuda H
PLoS One; 2023; 18(3):e0282965. PubMed ID: 36897916
[TBL] [Abstract][Full Text] [Related]
14. Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records.
Akiyama N; Shiroiwa T; Fukuda T; Murashima S; Hayashida K
PLoS One; 2018; 13(5):e0190392. PubMed ID: 29758026
[TBL] [Abstract][Full Text] [Related]
15. Predictors of the highest long-term care expenditures in Japan.
Olivares-Tirado P; Tamiya N; Kashiwagi M; Kashiwagi K
BMC Health Serv Res; 2011 May; 11():103. PubMed ID: 21575260
[TBL] [Abstract][Full Text] [Related]
16. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs.
Suehs BT; Shah SN; Davis CD; Alvir J; Faison WE; Patel NC; van Amerongen D; Bobula J
J Am Geriatr Soc; 2014 Mar; 62(3):435-41. PubMed ID: 24576203
[TBL] [Abstract][Full Text] [Related]
17. Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.
Nair R; Haynes VS; Siadaty M; Patel NC; Fleisher AS; Van Amerongen D; Witte MM; Downing AM; Fernandez LAH; Saundankar V; Ball DE
BMC Geriatr; 2018 Oct; 18(1):243. PubMed ID: 30326851
[TBL] [Abstract][Full Text] [Related]
18. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
[TBL] [Abstract][Full Text] [Related]
19. Long-term medical costs of Alzheimer's disease: matched cohort analysis.
Sopina E; Spackman E; Martikainen J; Waldemar G; Sørensen J
Eur J Health Econ; 2019 Apr; 20(3):333-342. PubMed ID: 30171490
[TBL] [Abstract][Full Text] [Related]
20. Trajectories of end-of-life medical and long-term care expenditures for older adults in Japan: retrospective longitudinal study using a large-scale linked database of medical and long-term care claims.
Teraoka E; Kunisawa S; Imanaka Y
BMC Geriatr; 2021 Jun; 21(1):403. PubMed ID: 34193081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
